These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17229964)

  • 1. Reversal of type 1 diabetes in mice.
    Faustman DL
    N Engl J Med; 2007 Jan; 356(3):311-2. PubMed ID: 17229964
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I.
    Kida K; Kaino Y; Ito T; Hirai H
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():327-33. PubMed ID: 9642663
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of type 1 diabetes in mice.
    Melton DA
    N Engl J Med; 2006 Jul; 355(1):89-90. PubMed ID: 16823003
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunology. Diabetes studies conflict on power of spleen cells.
    Couzin J
    Science; 2006 Mar; 311(5768):1694. PubMed ID: 16556811
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
    Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
    Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can insulin-dependent diabetes mellitus be cured or prevented? A status report on immunomodulatory strategies and pancreas transplantation.
    Drash AL; Arslanian SA
    Pediatr Clin North Am; 1990 Dec; 37(6):1467-87. PubMed ID: 2259549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 9. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
    Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D
    Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 11. Outlook for immune intervention in type I diabetes.
    Grob PJ
    Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
    [No Abstract]   [Full Text] [Related]  

  • 12. Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice.
    Zhang C; Todorov I; Lin CL; Atkinson M; Kandeel F; Forman S; Zeng D
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2337-42. PubMed ID: 17267595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in type 1 diabetes.
    Pozzilli P
    Diabet Med; 1988 Nov; 5(8):734-8. PubMed ID: 2975564
    [No Abstract]   [Full Text] [Related]  

  • 14. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
    Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
    Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene therapy for diabetes].
    Moritani M; Itakura M
    Nihon Rinsho; 1997 Nov; 55 Suppl():739-45. PubMed ID: 9434557
    [No Abstract]   [Full Text] [Related]  

  • 17. [Present status of therapeutics in diabetology].
    Leutenegger M; Grandmottet P
    Therapie; 1989; 44(4):239-43. PubMed ID: 2688183
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune intervention in type I diabetes mellitus--current clinical and experimental approaches.
    Kolb H
    Exp Clin Endocrinol; 1994; 102(4):269-72. PubMed ID: 7813597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of type I diabetes in NOD mice by linomide.
    Slavin S; Gross D; Weiss L
    Transplant Proc; 1995 Dec; 27(6):3240. PubMed ID: 8539933
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.